It looks like you're new here. If you want to get involved, click one of these buttons!
clacy, but it wasn't until PRPFX had such a great run that it became a board favorite. It's five year annualized return isn't anything to crow about either. I would wager most here succumbed to all the incessant articulate ramblings about the fund in the past five years. Just go back to 2011 in the MFO board archives on PRPFX.Since we're cherry picking data, holding PRPFX since 2000 would have yielded 7.7% CAGR vs 4.3% for SPY. Better sharpe, half the volatility and draw down as well.
Holding GLD since its inception has a slightly better return than SPY with roughly the same draw down and volatility.
So it can and does diversify, IMO.



Basically, you have a situation - even more than Apple (and Gilead has often been called the "Apple of Biotech") where the market is demanding to know more about what the next five years looks like.I haven't backed up the truck with GILD shares, although I did purchase some more shares last Thursday.
© 2015 Mutual Fund Observer. All rights reserved.
© 2015 Mutual Fund Observer. All rights reserved. Powered by Vanilla